The Phase 1b/2 open label study of CLD-101 will evaluate the safety and feasibility of administering multiple doses of CLD-101 in patients with newly diagnosed high-grade glioma. Eligible patients, ...
SCIENTISTS claim to have reversed a woman’s type 1 diabetes with a pioneering stem cell transplant. The 25-year-old had suffered from the chronic condition for more than a decade. She ...